Which of the following test is useful to distinguish between Insulinoma and Sulfonylurea related hypoglycemia:
**Core Concept**
Insulinoma and sulfonylurea-induced hypoglycemia are two distinct causes of low blood glucose levels. Insulinomas are rare tumors of the pancreas that produce excess insulin, leading to hypoglycemia. On the other hand, sulfonylureas are a class of oral antidiabetic drugs that stimulate insulin release from the pancreas, causing hypoglycemia as a side effect. Distinguishing between these two conditions is crucial for appropriate management.
**Why the Correct Answer is Right**
The **Glucose Tolerance Test (GTT)** is a diagnostic tool used to assess the body's ability to regulate blood glucose levels. In a GTT, an individual is given a high dose of glucose orally or intravenously, and blood glucose levels are monitored over time. In individuals with insulinoma, the GTT typically shows an exaggerated insulin response, leading to hypoglycemia. In contrast, individuals taking sulfonylureas will show an inappropriately high insulin response, but the hypoglycemia will not be as severe as in insulinoma patients due to the absence of a tumor. The GTT helps differentiate between these two conditions by assessing the body's ability to regulate insulin levels in response to glucose.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not relevant to the question. While a **Fasting Insulin Level** may be useful in assessing insulin resistance, it is not useful in distinguishing between insulinoma and sulfonylurea-induced hypoglycemia.
* **Option B:** A **C-peptide level** can help distinguish between endogenous insulin production (e.g., insulinoma) and exogenous insulin administration (e.g., insulin overdose). However, it is not specifically useful in distinguishing between insulinoma and sulfonylurea-induced hypoglycemia.
* **Option D:** A **24-hour Urine Catecholamine and Metanephrine** test is useful in diagnosing pheochromocytoma, not insulinoma or sulfonylurea-induced hypoglycemia.
**Clinical Pearl / High-Yield Fact**
The **Glucose Tolerance Test** is a critical diagnostic tool in distinguishing between insulinoma and sulfonylurea-induced hypoglycemia. Remember that insulinoma patients will show an exaggerated insulin response, while sulfonylurea patients will show an inappropriately high insulin response without severe hypoglycemia.
**Correct Answer:** C. Glucose Tolerance Test (GTT).